Ireland Oncology NGS Market (2025-2031) | Segmentation, Size & Revenue, Value, Growth, Outlook, Industry, Analysis, Companies, Forecast, Share, Competitive Landscape, Trends

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Ireland Country Macro Economic Indicators

3.2 Ireland Oncology NGS Market Revenues & Volume, 2021 & 2031F

3.3 Ireland Oncology NGS Market - Industry Life Cycle

3.4 Ireland Oncology NGS Market - Porter's Five Forces

3.5 Ireland Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 Ireland Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 Ireland Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F

3.8 Ireland Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F

3.9 Ireland Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in Ireland

4.2.2 Technological advancements in Next-Generation Sequencing (NGS) for oncology

4.2.3 Rising demand for personalized medicine in cancer treatment

4.3 Market Restraints

4.3.1 High cost associated with NGS testing

4.3.2 Limited reimbursement policies for NGS testing in oncology

4.3.3 Data privacy and security concerns related to genomic data in Ireland

6.1 Ireland Oncology NGS Market, By Technology

6.1.1 Overview and Analysis

6.1.2 Ireland Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 Ireland Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F

6.1.4 Ireland Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F

6.2 Ireland Oncology NGS Market, By Application

6.2.1 Overview and Analysis

6.2.2 Ireland Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F

6.2.3 Ireland Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F

6.3 Ireland Oncology NGS Market, By Service

6.3.1 Overview and Analysis

6.3.2 Ireland Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F

6.3.3 Ireland Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F

6.4 Ireland Oncology NGS Market, By Workflow

6.4.1 Overview and Analysis

6.4.2 Ireland Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F

6.4.3 Ireland Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F

6.4.4 Ireland Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F

6.5 Ireland Oncology NGS Market, By End-use

6.5.1 Overview and Analysis

6.5.2 Ireland Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F

6.5.3 Ireland Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F

6.5.4 Ireland Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F

6.5.5 Ireland Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F

6.5.6 Ireland Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F

7.1 Ireland Oncology NGS Market Export to Major Countries

7.2 Ireland Oncology NGS Market Imports from Major Countries

8.1 Adoption rate of NGS testing in oncology clinics

8.2 Number of clinical trials utilizing NGS technology in cancer research

8.3 Rate of integration of NGS results into oncology treatment protocols

9.1 Ireland Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 Ireland Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 Ireland Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F

9.4 Ireland Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F

9.5 Ireland Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F

10.1 Ireland Oncology NGS Market Revenue Share, By Companies, 2024

10.2 Ireland Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters